期刊文献+

隔离热灌注化疗治疗肢体恶性黑色素瘤的临床研究 被引量:5

Hyperthermic isolated limb perfusion chemotherapy treatment of malignant melanoma
原文传递
导出
摘要 目的恶性黑色素瘤(malignant melanoma,MM)是临床上较为常见的高度恶性肿瘤,长期以来致残率和死亡率相当高。本研究探讨隔离热灌注化疗(hyperthermic isolated limb perfusion,HILP)技术应用于MM的治疗效果,并总结热灌注经验。方法收集2002-01-01-2016-06-30甘肃省肿瘤医院骨与软组织肿瘤科收治的93例ⅡB~Ⅲ期肢体MM患者的临床资料,根据治疗方案,将72例HILP配合手术患者纳入观察组,21例未行HILP的手术患者为对照组,术后随访观察疗效、局部复发、转移、并发症及化疗毒性反应等情况,两组5年无瘤生存率(disease free survival,DFS)及5年总生存率(overall survival,OS)比较采用χ~2检验。结果观察组完全缓解率(complete response,CR)为63.9%(46/72),部分缓解率(partial response,PR)为26.4%(19/72),总缓解率(owerall response,OR)为90.3%,局部复发率(local recurrence,LR)为11.1%(8/72),保肢率(limb salvage,LS)为95.8%(69/72)。无死亡、致残等严重并发症,Wieberdink毒性反应分级均为Ⅰ~Ⅲ级。观察组与对照组5年DFS分别为44.4%(16/36)和14.3%(3/21),差异有统计学意义,P=0.02;5年OS分别为52.8%(19/36)和19.0%(4/21),差异有统计学意义,P=0.01。结论 HILP疗效确切,毒副作用小,且安全性高,能降低LR,提高5年DFS及OS,该技术可在临床上广泛推广及应用。 OBJECTIVE Malignant melanoma(MM)is a relatively common high incidence of malignant tumors,long-term disability and mortality is quite high.This study explored the treatment effective and summarize the practice experience of hyperthermic isolated limb perfusion(HILP)application in the Limb MM.METHODS The clinical data of93 patients with stageⅡB-Ⅲ MM were collected from January 2002 to June 2016.According to the treatment method,72 patients with HILP were the observation group and 21 patients without HILP were the control group.Compared the treatment effective rate,local recurrence,metastasis and chemotherapy toxicity after operation.The 5-year disease free survival rate(DFS)and 5-year overall survival rate(OS)were statisticed with theχ~2 test between the two groups.RESULTS In the observation group,the complete response rate(CR)was 63.9%(46/72),the partial response rate(PR)was26.4%(19/72),the CR(OR+PR)was 90.3%,the local recurrence rate was 11.1%(8/72),and limb salvage rate(LS)was 95.8%(69/72).No serious complications such as death,disability and other.Wieberdink toxicity grade was betweenⅠ-Ⅲ.The 5-year DFS was 44.4%(16/36)and 14.3%(3/21)in the observation group and control group respectively.The difference was significant statistically(P=0.02).The 5-year OS was 52.8%(19/36)and 19.0%(4/21)respectively.The difference was statistically(P=0.01).CONCLUSIONS HILP with exact effective,little toxicity and high security,can reduce LR and increase 5-year DFS and OS.This technique could be widely spreaded and used in clinical practice.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2017年第12期850-854,共5页 Chinese Journal of Cancer Prevention and Treatment
关键词 黑色素瘤 化学疗法 热灌注 肢体 生存率 melanoma chemotherapy perfusion extremities survival rate
  • 相关文献

参考文献3

二级参考文献39

  • 1徐世伟,陈芳,赵玉华.下肢骨肉瘤区域高温隔离灌注化疗方法学的探讨[J].中华肿瘤杂志,1994,16(4):310-313. 被引量:9
  • 2夏贤良,杨迪生,范顺武,黄宗坚,许文根,徐少文,陶惠民,何荣新.下肢骨肉瘤高温隔离灌注化疗初步报告[J].中华骨科杂志,1994,14(11):645-648. 被引量:26
  • 3杨蕴,宋金钢,张瑾,张允祥.热或热药区域灌注治疗下肢恶性黑色素瘤(附5例报告)[J].中国肿瘤临床,1995,22(12):846-848. 被引量:1
  • 4常国栋,李壮林,秦加阳,马翠卿,罗永章,许平.重组人血管内皮抑制素(rh-Endostatin)大肠杆菌表达体系发酵条件的优化[J].生物工程学报,2005,21(4):662-666. 被引量:26
  • 5Creech OJ Jr,Kremcntz ET,Ryan RF,et al.Chemotherapy of cancer:regional perfusion utilizing an extracorporeal drcuit[J].Ann Surg,1958,148(4):616-632.
  • 6Eggermont AM,Schraffordt Koops H,Lienard D,et al.Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas:a multicenter trial[[].J Clin Oncol,1996,14(10):2653-2665.
  • 7Lienard D,Ewalenko P,Delmotte JJ,et al.High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma[J].J Clin Oncol,1992,10(1):52-60.
  • 8Hohenberger P,Kettelhack C,Hermann A,et al.Functional outcome after preoperative isolated limb perfusion with rhtnfalpha/mel-phalan for high-grade extremity sarcoma[J].Eur J Cancer,2001,37:s34-s35.
  • 9Ponte P,Moniz JV,Farricha V,et al.Merkel cell carcinoma:an unusual indication for isolated limb perfusion[J].Dermatol Online J.2008,14(7):6.
  • 10Sato T, Sawaji Y, Matsui N, et al. Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion. Biochem Biophys Res Commun, 1999, 265:189-193.

共引文献28

同被引文献43

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部